Journal Information
Vol. 14. Issue 5.
Pages 468-475 (September - October 2010)
Share
Share
Download PDF
More article options
Vol. 14. Issue 5.
Pages 468-475 (September - October 2010)
Original article
Open Access
HLA-Bw4-B*57 and Cw*18 alleles are associated with plasma viral load modulation in HIV-1 infected individuals in Salvador, Brazil
Visits
2272
Edinete Melo da Silva1,2,
Corresponding author
edinete@yahoo.com

Correspondence to: Laboratório de Pesquisa em Infectologia, Hospital Universitário Professor Edgard Santos Rua Augusto Viana, S/N-Canela, 6° andar, Salvador – Bahia – Brazil CEP: 40110-060, Phone: +55-71-32838126; Fax: +55-71-32472756.
, Angelina Xavier Acosta2,3, Eduardo José Melo Santos3, Eduardo Martins Netto1, Denise Carneiro Lemaire4, Adriano Silva Oliveira1, Carolina Matos Barbosa5, Maria Teresita Bendicho4, Bernardo Galvão-Castro2, Carlos Brites1
1 Infectology Research Laboratory of Hospital Universitário Professor Edgard Santos – HUPES – UFBA, Brazil
2 Advanced Laboratory of Public Health - LASP/ CPQGM/FIOCRUZ, Brazil
3 Department of Pediatrics, School of Medicine, UFBA, Brazill
4 Laboratory of Immunology of Instituto das Ciências e Saúde - ICS/UFBA, Salvador – BA, Brazil
5 Laboratory of Humam and Medical Genetics, Biological Sciences Center, UFPA, Belém – PA, Brazil
This item has received

Under a Creative Commons license
Article information
Abstract

Host genetic factors play an important role in mediating resistance to HIV-1 infection and may modify the course of infection. HLA-B alleles (Bw4 epitope; B*27 and B*57) as well as killer cell immunoglobulin-like receptors have been associated with slow progression of HIV-1 infection. Objective: To evaluate the association between serological epitopes HLA-Bw4 and HLA-Bw6 and prognostic markers in AIDS. Methods: 147 HIV-infected individuals in Bahia, Northeast Brazil, were genotyped for HLA class I locus. HLA class I genotyping was performed by hybridization with sequence-specific oligonucleotide probes following amplification of the corresponding HLA-A, HLA-B and HLA-C genes. Statistical analysis was performed using Fisher¿s exact and ANOVA tests for categorical and continuous variables, respectively. Results: We detected a significant association (χ2 = 4.856; p = 0.018) between the presence of HLA-Bw4 and low levels of viremia. Eighteen out of the 147 HIV-infected individuals presented viremia ≤ 1,800 copies/mL and 129 presented viremia > 2,000 copies/mL. Ninety and four percent (17/18) of all individuals with viremia ≤ 1,800 copies/ mL carried HLA-Bw4, compared to 67.4% (87/129) of individuals with viremia > 2,000 copies/mL. Additionally, we found a significantly higher frequency of B*57 (OR = 13.94; 95% CI = 4.19-46.38; p < 0.0001) and Cw*18 (OR = 16.15; 95% CI = 3.46-75.43; p ≤ 0.0001) alleles, favoring the group with lower viremia levels, in comparison with those with higher viral load. Conclusion: HLA-Bw4-B*57 and Cw*18 alleles are associated with lower level of viral load in HIV-infected Brazilian patients. These findings may help us in understanding the determinants of HIV evolution in Brazilian patients, as well as in providing important information on immune response correlates of protection for such population.

Keywords:
HIV
AIDS
MHC
HLA
polymorphism
Full text is only aviable in PDF
References
[1]
K. Abbas.
Complexo de histocompatibilidade principal.
Biologia celular e molecular,
[2]
M. Magierowska, I. Theodorou, P. Debré, et al.
Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1 infected individuals.
Blood, 93 (1999), pp. 936-941
[3]
S.A. Migueles, M.S. Sabbaghian, W.L. Shupert, et al.
HLAB*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.
Proc Natl Acad Sci USA, 97 (2000), pp. 2709-2714
[4]
R.A. Kaslow, C. Rivers, J. Tang, et al.
Polimorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type I infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines.
J Virol, 75 (2001), pp. 8681-8689
[5]
M. Altfeld, M.M. Addo, E.S. Rosenberg, et al.
Influence of HLAB57 on clinical presentation and viral control during acute HIV-1 infection.
[6]
A. López-Vázquez, A. Mina-Blanco, J. Martinéz-Borra, et al.
Interaction between KIR3DL1 and HLA-B*57 supertype alleles influences the progression of HIV-1 infection in a Zambian population.
Hum Immunol, 66 (2005), pp. 285-289
[7]
G. Pantaleo, C. Graziosi, J.F. Demarest, et al.
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.
Nature, 362 (1993), pp. 355-358
[8]
G. Pantaleo, A.S. Fauci.
New concepts in the immunopathogenesis of HIV infection.
Annu Rev Immunol, 13 (1995), pp. 487-512
[9]
P. Borrow, H. Lewicki, X. Wei, et al.
Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.
Nat Med, 3 (1997), pp. 205-211
[10]
R.A. Koup, J.T. Safrit, Y. Cao, et al.
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
J Virol, 68 (1994), pp. 4650-4655
[11]
C. Rinaldo, X. Huang, Z. Fan, et al.
High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic Tlymphocyte activity and low viral load are associated with lack of disese in HIV-1-infected long-term nonprogressors.
J Virol, 69 (1995), pp. 5838-5842
[12]
Y. Chen, C. Rinaldo, P. Gupta.
A semiquantitative assay for CD8+ T-cell-mediated suppression of human immunodeficiency virus type 1 infection.
Clin Diagn Lab Immunol, 4 (1997), pp. 4-10
[13]
Y. Cao, L. Qin, L. Zhang, et al.
Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.
New Engl J Med, 332 (1995), pp. 201-208
[14]
T. Harrer, E. Harrer, S.A. Kalams, et al.
Citotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection: Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.
J Immunol, 156 (1996), pp. 2616-2623
[15]
C.C. Winter, J.E. Gumperz, P. Parham, E.O. Long, N. Wagtmann.
Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.
J Immunol, 161 (1998), pp. 571-577
[16]
N. Wagtmann, S. Rajagopalan, C.C. Winter, et al.
Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer.
Immunity, 3 (1995), pp. 801-809
[17]
C.A. Muller, G. Engler-Blum, V. Gekeler, et al.
Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6.
Immunogenetics, 30 (1989), pp. 200-207
[18]
M. Cella, A. Longo, G.B. Ferrara, J.L. Strominger, M. Colonna.
NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80.
J Exp Med, 180 (1994), pp. 1235-1242
[19]
J.E. Gumperz, V. Litwin, J.H. Phillips, et al.
The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.
J Exp Med, 181 (1995), pp. 1133-1144
[20]
H. Bruunsgaard, C. Pedersen, P. Skinhoj, B.K. Pedersen.
Clinical progression of HIV infection: Role of NK cells.
Scand J Immunol, 46 (1997), pp. 91-95
[21]
M.P. Martin, X. Gao, J. Lee, et al.
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.
Nat Genet, 31 (2002), pp. 429-434
[22]
A.L. Hultström, G. Bratt, A. Cosma, et al.
Autologous cytotoxicity of natural killer cells derived from HIV-infected patients.
Immunol Letters, 91 (2004), pp. 155-158
[23]
P.O. Flores-Villanueva, E.J. Yunis, J.C. Delgado, et al.
Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity.
Proc Natl Acad Sci USA, 98 (2001), pp. 5140-5145
[24]
Y. Qi, M.P. Martin, X. Gao, et al.
KIR/HLA pleiotropism: protection against both HIV and opportunistic infections.
Plos Pathogens, 2 (2006), pp. 741-745
[25]
T.M. Welzel, X. Gao, R.M. Pfeiffer, et al.
HLA-B Bw4 alleles and HIV-1 transmission in heterosexual couples.
[26]
J. Alves-Silva, M.S. Santos, P.E.M. Guimarães, et al.
The ancestry of Brazilian mtDNA lineages.
Am J Human Genet, 67 (2000), pp. 444-461
[27]
D.R. Carvalho-Silva, F.R. Santos, J. Rocha, S.D.J. Pena.
The phylogeography of Brazilian Y-chromosome lineages.
Am J Hum Genet, 68 (2001), pp. 281-286
[28]
K. Abe-Sandes, W.A. Silva Jr., M.A. Zago.
Heterogeneity of the Y chromosome in Afro-Brazilian populations.
Human Biology, 76 (2004), pp. 77-86
[29]
B.D. Walker.
Elite control of HIV infection: implications for vaccines and treatments.
International AIDS Society, 15 (2007), pp. 134-136
[30]
HLA Class I Sequence Alignments http://www.anthonynolan.org.uk/HIG/data.html.
[31]
M. Raymond, F. Rousset.
Population genetics software for exact- tests and ecumenicism. Genepop version 1.2.
J Hered, 86 (1995), pp. 248-249
[32]
J.E. Schmitz, M.J. Kuroda, S. Santra, et al.
Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.
Science, 283 (1999), pp. 857-860
[33]
A. Lazaryan, E. Lobashevsky, J. Mulenga, et al.
Human leukocyte antigen B58 supertype and human immunodeficiency virus type 1 infection in native africans.
J Virol, 80 (2006), pp. 6056-6060
[34]
A.A. Bashirova, M.P. Martin, D.W. McVicar, et al.
The killer immunoglobulin- like receptor gene cluster: tuning the genome for defense.
Annu Rev Genomics Hum Genet, 7 (2006), pp. 277-300
[35]
M.P. Martin, Y. Qi, X. Gao, et al.
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.
Nat Genet, 39 (2007), pp. 733-740
[36]
D.R. Carvalho-Silva, E. Tarazona-Santos, J. Rocha, et al.
Y chromosome diversity in Brazilians: switching perspectives from slow to fast envolving markers.
Genetica, 126 (2006), pp. 251-260
[37]
A.A.L. Barbosa, S.M.B. Sousa, K. Abe-Sandes, et al.
Microsatellite studies on an isolated population of African descent in the Brazilian state of Bahia.
Genet Mol Biol, 29 (2006), pp. 23-30
Copyright © 2010. Elsevier Editora Ltda.. All rights reserved
The Brazilian Journal of Infectious Diseases
Article options
Tools